TrialPath
Recruiting

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

NCT03260842 · Stanford University
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
Observational study to collect bio-specimens from 2 separate patient cohorts identified to be at high risk for subsequent development of pancreas cancer. 1. Patients diagnosed with a pancreatic cyst undergoing either endoscopic ultrasound or surgery. Bio-specimens collected include pancreatic cyst fluid and blood. These will be collected using a standard operating protocol. 2. Patients defined as a high risk individual for pancreas cancer by family history and/or known genetic mutations. Bio-specimens collected include blood. This will be collected using a standard operating protocol.
Eligibility criteria
Inclusion Criteria: * Older than 18 with pancreas cyst * Older than 18 at high risk for Pancreas cancer Exclusion Criteria: * Unable to provide consent * Not willing to provide bio-specimens
Study design
Enrollment target: 500 participants
Age groups: adult, older_adult
Timeline
Starts: 2017-09-01
Estimated completion: 2030-04-30
Last updated: 2025-04-01
Interventions
Diagnostic Test: Bio-Specimen Collection
Primary outcomes
  • Pancreas Cancer (5-10 years)
Sponsor
Stanford University · other
Contacts & investigators
ContactWalter Park, MD · contact · wgpark@stanford.edu · 650-723-4102
ContactSharon Pneh · contact · spneh@stanford.edu · 650-724-1336
InvestigatorWalter Park, MD · principal_investigator, Faculty
All locations (1)
Stanford UniversityRecruiting
Stanford, California, United States
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer · TrialPath